Accelerating Innovation for Competitive Advantage in Pharmaceutical Manufacturing

Overview:

Accelerating Innovation for Competitive Advantage in Pharmaceutical Manufacturing

As globalization expands and competitive pressures intensify, discrete and process manufacturing organizations, including pharmaceutical companies, experience increasing price pressure from customers/suppliers and high expectations for profitable growth from investors and shareholders. To respond to these challenges, product companies must accelerate innovation and achieve a higher level of efficiency to remain competitive and drive top-line growth. This white paper explains the process.

Author: Accelrys

Find more white papers on Operational Excellence & Lean Six Sigma

View all white papers»